<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, management of influenza-like symptoms might encompass potentially inappropriate expenditures including unnecessary emergency visits, or inappropriate pharmacological management [
 <xref rid="pone.0202787.ref004" ref-type="bibr">4</xref>]. For example, the problem of antivirals, such as oseltamivir, being prescribed to patients who do not actually have influenza is widely acknowledged among the medical community. Conversely, inappropriate prescriptions of antibiotics to laboratory-confirmed influenza patients has been reported to be as high as 30% in five US centers [
 <xref rid="pone.0202787.ref005" ref-type="bibr">5</xref>]. Not only such practices prompt unnecessary costs to the health-care system and longer time to recovery for patients, but ultimately, they may also favor the emergency of drug-resistant infections in the long term.
</p>
